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-Catenin gets an honorable discharge
B
eta-catenin binds E-cadherin to 
facilitate the formation of inter-
cellular adhesions, but it’s also a 
central component of the Wnt signaling 
pathway that controls cell proliferation 
and differentiation (1). Activation of the 
Wnt pathway stabilizes -catenin, enabling 
it to translocate into the nucleus and pair 
up with transcription factors to induce tar-
get gene expression. In the absence of a 
Wnt signal, -catenin’s activity is kept in 
check by its sequestration at cell junctions 
and by the kinase GSK-3, which phos-
phorylates the protein to trigger its ubiquit-
ination and degradation by the proteasome. 
Chairoungdua et al. reveal a new way in 
which cells restrain -catenin and poten-
tially suppress tumor metastasis: the protein 
can be ejected from cells in small vesicles 
called exosomes (2).
Michael Caplan’s group at Yale Uni-
versity uncovered this process after fi  nd-
ing that E-cadherin binds to CD82, a 
member of the tetraspanin family of 
transmembrane proteins, which are in-
volved in a variety of dif-
ferent cellular processes 
including cell adhesion 
and signal transduction (3). 
Overexpressing CD82 or a 
related tetraspanin called 
CD9 suppressed Wnt signal-
ing and reduced -catenin 
protein levels. Surprising-
ly, this decrease did not 
involve GSK-3 or the 
proteasome. Nor did it in-
volve protein degradation by lysosomes. 
“We were sort of stumped,” Caplan admits, 
“until we saw a talk that mentioned that 
tetraspanins like CD82 are associated 
with exosomes.”
Exosomes are small vesicles that form 
inside endosomes by the inward budding 
of endosomal membranes. The vesicles 
are then secreted when the endosome fuses 
with the plasma membrane (4). Chair-
oungdua et al. found that CD9 and CD82 
boosted the release of exosomes contain-
ing -catenin, thereby reducing cellular 
levels of the protein and inhibiting the 
Wnt pathway. Cells lacking CD9, on the 
other hand, produced fewer exosomes and 
showed higher Wnt signaling activity.
“We think that these tetraspanins facili-
tate exosome biogenesis,” says Caplan. 
Tetraspanins associate with each other to 
form patches within cell membranes that, 
in concert with specific lipids, might 
induce vesicle budding 
into the endosomal lumen. 
-Catenin could be tar-
geted to these vesicles 
through the interaction of 
E-cadherin with tetraspa-
nins. E-cadherin was also 
found in exosomes and 
CD82 didn’t affect Wnt 
signaling when it was 
overexpressed in cells 
lacking the adhesion mol-
ecule. Caplan and colleagues now want to 
investigate whether this is how tetraspan-
ins target -catenin to exosomes.
The exosomal release of -catenin 
may be compromised in certain cancers, 
where Wnt signaling is often hyperactive. 
CD82 and CD9 are both suppressors of 
metastasis whose expression is lost in 
several types of late stage tumor. Chair-
oungdua et al. could block Wnt signaling 
in a metastatic cell line by restoring CD82 
expression. “CD82 may act as a metasta-
sis suppressor by targeting -catenin for 
exosomal release and thereby reducing its 
availability as a Wnt signaling mediator,” 
Caplan proposes.
But why would cells use tetraspanins 
and exosomes to dispose of -catenin 
when they already have GSK-3 and the 
proteasome to get rid of the protein? Or, 
as Caplan puts it: “Why throw -catenin 
overboard instead of simply grinding it up? 
One possibility is that exosomal -catenin 
is like a message in a bottle that signals to 
neighboring cells.” Exosomes have previ-
ously been shown to transmit messages 
between cells. They can, for example, 
deliver microRNAs from one cell to regu-
late mRNAs in a second (5). Alternatively, 
exosomes may be a more reversible way 
for cells to lower their -catenin levels. 
“Incorporating  -catenin into exosomes 
could mark it for destruction without actu-
ally destroying it,” Caplan explains. “Our 
paper is a proof of principle for this mecha-
nism. Now we have to establish if and how 
this process is regulated.”
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Arthit Chairoungdua (left), Michael Caplan   
(right), and colleagues reveal a new mecha-
nism by which cells downregulate -catenin 
protein levels and activity of the Wnt sig-
naling pathway. The tetraspanin proteins 
CD82 and CD9 promote the incorporation 
of -catenin into exosomes—small vesicles 
that cells release into their environment. 
Electron microscopy of puriﬁ  ed cell culture 
supernatants reveals that cells overexpress-
ing CD9 (middle) or CD82 (right) produce 
more exosomes than control cells (left). 
Exosomal release of -catenin and inhi-
bition of Wnt signaling may explain why 
CD82 and CD9 suppress tumor metastasis.
“CD82 may act 
as a metastasis 
suppressor 
by targeting 
-catenin for 
exosomal 
release.”
Wnt signaling component is removed from active duty by exosomes.
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